Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

Healthcare providers have struggled with data interoperability since the advent of the EHR decades ago, failing to fully connect patient information across systems. They may have an unlikely model to ...

The archaic practice of removing blood from the body to treat a wide range of illnesses lives on today as a standard treatment for certain blood disorders. The modern version of this approach, called ...

Empathy Health Technologies announced Wednesday that it raised $7.6 million to support its Sober Sidekick app, which helps prevent relapse by connecting those struggling with substance use disorder ...

The deadline for extending the Affordable Care Act subsidies is approaching this month. This is happening even as consumers who depend on the ACA Marketplace are faced with the tough decision. Should ...

A Pharvaris drug led to speedy relief and symptom resolution from the sudden swelling attacks caused by a rare genetic disorder, preliminary Phase 3 clinical trial results that pave the way for an FDA ...

The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

Samsung Healthcare unveiled a new ultrasound system this week designed to boost diagnostic accuracy and efficiency. The system, named the R20, finally brings the full weight of Samsung Electronics’ AI ...

As employers brace for significant healthcare cost increases in 2026, many are seeking out innovative strategies to manage the impact. This comes from the Business Group on Health’s newly released ...

Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...